Signals were just the beginning. Fundz is what’s next.
Only Fundz brings more than a dozen live business signals together on each company, ranks every company against your ICP, and each morning delivers the best: who to reach out to, why, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Vinci Pharmaceuticals Inc. closes over $8 million Series A financing to advance its EPIPLANT™ drug delivery platform.
PRIVATEOct 08, 2026
Amount Raised
$8 Million
Round Type
Series A
Avon By The SeaHealthcare
Investors
MintPharma CapitalDynagrow Capital, LLLP
Description
Vinci Pharmaceuticals Inc. has successfully closed an $8+ million Series A financing round to further develop its EPIPLANT™ delivery platform. The financing was led by Dynagrow Capital, LLLP, with participation from MintPharma Capital. The funds will support GMP manufacturing and future clinical studies
Company Information
Company
Vinci Pharmaceuticals, Inc.
Location
12 WASHINGTON AVENUE
Avon By The Sea, New Jersey, United States
Fundz sees it the moment Vinci Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.